GLENMARK PHARMACEUTICALS LIMITED

MUMBAI ■ 1977 ■ ACTIVE

Details as on Nov 20, 2016

Company Introduction

GLENMARK PHARMACEUTICALS LIMITED is a Public Company limited by Shares. It is registered with Registrar of Companies, Mumbai on Nov 18, 1977.

Current Status of Glenmark Pharmaceuticals Limited is Active.

It is a Non-govt company with an Authorized Capital of ₹ 277,00,00,000 (Two Hundred Seventyseven Crore Indian Rupees) and Paid Up Capital of ₹ 28,21,58,156 (Twentyeight Crore, Twentyone Lakh, Fiftyeight Thousand, One Hundred And Fiftysix Indian Rupees).

There are 10 Directors associated with Glenmark Pharmaceuticals Limited. They are: Glenn Mario Saldanha, Julio Francis Ribeiro, Rajesh Vasudeo Desai, Sridhar Gorthi, Cherylann Maria Pinto, Devendra Raj Mehta, Blanche Elizabeth Saldanha, Bernard Hubert Munos, Brian William Tempest and Milind Shripad Sarwate.

There is one Signatory (Sanjay Kumar Chowdhary) associated with Glenmark Pharmaceuticals Limited.

As per the records of Ministry of Corporate Affairs (MCA), Glenmark Pharmaceuticals Limited's last Annual General Meeting (AGM) was held on Aug 12, 2016, and the date of lastest Balance Sheet is Mar 31, 2016.

Corporate Identification Number (CIN) of Glenmark Pharmaceuticals Limited is L24299MH1977PLC019982 and its Registration Number is 019982. Its Registered Address and Contact Email are 'B-2MAHALAXMI CHAMBERS22 BHULABHAI DESAI ROAD MAHALAXMI MUMBAI MH 400026 IN' and complianceofficer@glenmarkpharma.com respectively.

Found anything out-of-order? Please report.

Company Details

CIN L24299MH1977PLC019982
Company Name GLENMARK PHARMACEUTICALS LIMITED
Company Status Active
Date of Incorporation Nov 18, 1977
RoC RoC-Mumbai
Registration Number 019982
Company Category Company limited by Shares
Company Sub-Category Non-govt company
Class of Company Public
Authorized Capital ₹ 277,00,00,000 (Two Hundred Seventyseven Crore Indian Rupees)
Paid Up Capital ₹ 28,21,58,156 (Twentyeight Crore, Twentyone Lakh, Fiftyeight Thousand, One Hundred And Fiftysix Indian Rupees)
Number of Members -
Listing Status Listed
Date of Last Annual General Meeting (AGM) Aug 12, 2016
Date of Latest Balance Sheet Mar 31, 2016

Contact Details

Registered Address B-2MAHALAXMI CHAMBERS22 BHULABHAI DESAI ROAD MAHALAXMI MUMBAI MH 400026 IN
Email complianceofficer@glenmarkpharma.com

Director / Signatory Details

Charges Details

Charge Amount Assets Under Charge Created On Last Modified On Status
₹ 780,00,00,000 (Seven Hundred Eighty Crore Indian Rupees) Immovable property or any interest therein; Book debts; Stocks May 21, 1985 Mar 29, 2016 OPEN
₹ 50,00,00,000 (Fifty Crore Indian Rupees) Immovable property or any interest therein May 10, 2005 - CLOSED
₹ 25,00,00,000 (Twentyfive Crore Indian Rupees) Immovable property or any interest therein Nov 25, 2004 - CLOSED
₹ 60,00,00,000 (Sixty Crore Indian Rupees) Immovable property or any interest therein Jul 29, 2009 - CLOSED
₹ 10,00,00,000 (Ten Crore Indian Rupees) Movable property (not being pledge) Sep 23, 2004 - OPEN
₹ 75,00,00,000 (Seventyfive Crore Indian Rupees) Jun 18, 2009 Apr 15, 2011 CLOSED
₹ 10,00,00,000 (Ten Crore Indian Rupees) Movable property (not being pledge) Sep 23, 2004 - CLOSED
₹ 170,00,00,000 (One Hundred Seventy Crore Indian Rupees) Jun 9, 2008 Dec 19, 2008 OPEN
₹ 50,00,00,000 (Fifty Crore Indian Rupees) Movable property (not being pledge) Aug 3, 2004 - CLOSED
₹ 200,00,00,000 (Two Hundred Crore Indian Rupees) Sep 12, 2007 Apr 7, 2008 CLOSED
₹ 200,00,00,000 (Two Hundred Crore Indian Rupees) Sep 12, 2007 Apr 7, 2008 CLOSED
₹ 15,00,00,000 (Fifteen Crore Indian Rupees) Movable property (not being pledge) Apr 2, 2004 - CLOSED
₹ 150,00,00,000 (One Hundred Fifty Crore Indian Rupees) Jan 16, 2009 Oct 20, 2009 CLOSED
₹ 25,00,00,000 (Twentyfive Crore Indian Rupees) Movable property (not being pledge) May 10, 2004 - CLOSED

Report Information Discrepancy

Though we take utmost care to ensure that the data we present is up-to-date, due to frequent changes in Corporate Information, it is possible that some details you see may be out-of-date occasionally. If you notice any discrepancy, please help by reporting it to us.

We appreciate your time!